"We obviously still need to manage the short-term challenges but, as an industry, we have to show leadership on the future and working with the government to ensure Australian patients are in a position to access these new technologies," says Novartis' Lauren Carey. …
Lauren Carey: Review a 'great opportunity' to shape future
September 18, 2019 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
Immutep reports promising new data in head and neck cancer at ESMO immuno-oncology 2024
December 12, 2024 - - Australian Biotech -
What could the HTA Review change for patients who waited for this cancer therapy?
December 12, 2024 - - Latest News -
Health groups call for dying patients to receive free pain relief amid medicines shortage
December 12, 2024 - - Latest News -
QIMR Berghofer says cell therapy saving lives of immunocompromised patients
December 11, 2024 - - Australian Biotech -
Leafio opens Sydney distribution facility to deliver same-day medical cannabis to metro pharmacies
December 11, 2024 - - Latest News -
AusBiotech and BioMelbourne Network welcome Victoria's economic growth statement
December 11, 2024 - - Australian Biotech -
DHL constructing largest automated life sciences warehouse footprint in the Southern Hemisphere
December 11, 2024 - - Latest News